Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Sun Pharmaceutical Industries Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524715
ISIN Demat	INE044A01036
Book Value	99.25

NSE Code	SUNPHARMA
Dividend Yield %	0.89
Market Cap	4305126.74

P/E	95.69
EPS	18.75
Face Value	1


	BSE		NSE

12-Dec-2025

Last Price	1794.30
Net Change	-12.6
% Change	-0.7%
Prev.Close	1806.90
Open	1818.95
High	1818.95
Low	1791.15
Volume	27520

Last Price	1793.50
Net Change	-13.7
% Change	-0.76%
Prev.Close	1807.20
Open	1808.00
High	1811.80
Low	1791.00
Volume	1442309

Value	49601947
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1818.95
52-Week High	1910.00
52-Week Low	1547.25

Value	2593798717
Best Buy	0.00
Best Sell	1793.50
Best Quantity	0
Sell Quantity	3
Today's Range	1811.80
52-Week High	1910.00
52-Week Low	1548.00

Open Price	1811.30
High Price	1815.30
Low Price	1798.80
Last Price	1801.30
Prev Close	1811.10
Change	-9.80
% Change	-0.54 %

Average Price	1805.68
Underlying Value	1793.50
Number of contracts traded	2768
Turnover in Rs. Lakhs	17493
Open Interest	13858250.00
Change in O I	-211400.00
% Change in O I	-1.50 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	3
Price	1793.50

Best Bid

Best Offer

Quantity	350
Price	1800.7

Quantity	350
Price	1802.8

Holding Details

Latest Corporate Events

Bonus

1 : 1

29-Jul-13

Book Closure

25-Aug-21

31-Aug-21

Dividend

550 %

07-Jul-25

Company News

03-12-2025

Sun Pharmaceutical Indust...

03-12-2025

Sun Pharmaceutical Indust...

01-12-2025

Sun Pharma launches ILUMY...

01-12-2025

Sun Pharmaceutical Indus...

26-11-2025

Sun Pharmaceutical Indust...

18-11-2025

Sun Pharma, AstraZeneca P...

11-11-2025

Sun Pharmaceutical Indust...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.